secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2025-01-28T23:59:59+00:00
Accession:  0000310764-25-000005
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q4 adjusted EPS up 15.9% to $4.01, organic sales +10.2%; guides 2025 8-9% growth
--------------------------------------------------------------------------------

- Reported EPS fell 52.7% to $1.41 due to $818M goodwill/impairment charges on Spine; adjusted EPS rose 15.9% to $4.01.
- Organic net sales increased 10.2% in Q4 and full year 2024, driven by 9.1% volume growth and 1.1% price.
- Full-year adjusted operating margin expanded 110 bps to 25.3%; reported operating margin was 16.3%.
- 2025 guidance: organic sales growth 8-9%, adjusted EPS $13.45-$13.70; Inari acquisition expected to close late Feb with ~$590M stub sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076425000005/0000310764-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076425000005/syk-20250128.htm
  HTML page:      https://secwatch.observer/filing/0000310764-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer